Diagnosis of invasive fungal infections using real-time PCR assay in paediatric acute leukaemia induction

Mycoses

Volumn 55, Issue 4, 2012, Pages 372-379

  Mandhaniya, Sushil ^a   Iqbal, Sobuhi ^a   Sharawat, Surender Kumar ^a   Xess, Immaculata ^a   Bakhshi, Sameer ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Acute leukaemia; Aspergillosis; Fungal DNA; Induction; Invasive fungal infection diagnosis; Paediatric; Real time PCR

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; CARBAPENEM; CEFTRIAXONE; EDETIC ACID; FUNGAL DNA; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; VANCOMYCIN; VORICONAZOLE;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLOSIS; BLOOD SAMPLING; CANDIDIASIS; CHILD; CHILD HOSPITALIZATION; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEBRILE NEUTROPENIA; FEMALE; HEALTH CARE COST; HUMAN; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUCORMYCOSIS; PNEUMONIA; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SYSTEMIC MYCOSIS;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA; MALE; MYCOSES; REAL-TIME POLYMERASE CHAIN REACTION; REMISSION INDUCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

ASPERGILLUS; CANDIDA; NUCLEOPOLYHEDROVIRUS;

EID: 84862241473     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02157.x     Document Type: Article

References (37)

1. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-66.
2. Pannutti C, Gingrich R, Pfaller MA, Kao C, Wenzel RP. Nosocomial pneumonia in patients having bone marrow transplant. Cancer 1992; 69: 2653-62.
3. Meyers JD. Fungal infections in bone marrow transplant patients. Semin Oncol 1990; 17: 10-3.
4. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 89-96.
5. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1990; 12: 310-50.
6. Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 2003; 33: 453-60.
7. Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003; 3: 230-40.
8. Mennink-Kersten MASH, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349-57.
9. Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin Infect Dis 1995; 20: 598-605.
10. Quindos G. New microbiological techniques for the diagnosis of invasive mycoses caused by filamentous fungi. Clin Microbiol Infect 2006; 12(Suppl. 7): 40-52.
11. Wheat LJ. Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis 2006; 8: 128-39.
12. Bart-Delabesse E, Basile M, AL Jijakli A et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005; 43: 5214-20.
13. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762-9.
14. Herbrecht R, Letscher-Bru V, Oprea C et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-906.
15. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 2006; 42: 479-86.
16. Donnelly JP. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a way to go. Clin Infect Dis 2006; 42: 487-9.
17. Kami M, Fukui T, Ogawa S et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001; 33: 1504-12.
18. Speiss B, Buchheidt D, Baust C et al. Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical specimens from neutropenic patients. J Clin Microbiol 2003; 41: 1811-8.
19. Loeffler J, Henke N, Herbart H et al. Quantification of fungal DNA by using fluorescence resonance energy transfer and the Light Cycler system. J Clin Microbiol 2000; 38: 586-90.
20. Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XY. Diagnosis of invasive mold infection by real-time quantitative PCR. Am J Clin Pathol 2003; 119: 38-44.
21. Baskova L, Landlinger C, Preuner S, Lion T. The Pan-AC assay: a single-reaction real-time PCR test for quantitative detection of a broad range of Aspergillus and Candida species. J Med Microbiol 2007; 56: 1167-73.
22. Schabereiter-Gurtner C, Selitsch B, Rotter ML, Hirschl AM, Willinger B. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J Clin Microbiol 2007; 45: 906-14.
23. Florent M, Katsahian S, Vekhoff A et al. Prospective evaluation of polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 2006; 193: 741-7.
24. Jordanides NE, Allan EK, McLintock LA et al. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients. Bone Marrow Transplant 2005; 35: 389-95.
25. Halliday C, Hoile R, Sorrell T et al. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br J Haematol 2006; 132: 478-86.
26. Hummel M, Buchheidt D. Molecular and serological diagnosis of invasive aspergillosis: new answers to old questions? Mycoses 2007; 50: 18-23.
27. Roilides E. Early diagnosis of invasive aspergillosis in infants and children. Med Mycol 2006; 44: 199-205.
28. Costa C, Vidaud D, Olivi M, Bart-Delabesse E, Vidaud M, Bretagne S. Development of two real-time quantitative TaqMan PCR assays to detect circulating Aspergillus fumigatus DNA in serum. J Microbiol Methods 2001; 44: 263-9.
29. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis 2008; 46: 1813-21.
30. Kawazu M, Kanda Y, Nannya Y et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-β-d-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733-41.
31. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as non invasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-10.
32. Buchheidt D, Baust C, Skladny H et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step PCR: clinical results. Clin Infect Dis 2001; 33: 428-35.
33. Pinel C, Fricker-Hidalgo H, Lebeau B et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J ClinMicrobiol 2003; 41: 2184-6.
34. Robenshtok E, Gafter-Gvili A, Goldberg E et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 2007; 25: 5471-89.
35. White PL, Perry MD, Loeffler J et al. Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol 2010; 48: 3753-5.
36. Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845-51.
37. Winston DJ, Chandrasekar PH, Lazarus HM et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized, placebo-controlled, double blind, multicenter trial. Ann Intern Med 1993; 118: 495-503.